Does TOLVAPTAN Cause Off label use? 560 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 560 reports of Off label use have been filed in association with TOLVAPTAN (Jynarque). This represents 6.2% of all adverse event reports for TOLVAPTAN.
560
Reports of Off label use with TOLVAPTAN
6.2%
of all TOLVAPTAN reports
63
Deaths
69
Hospitalizations
How Dangerous Is Off label use From TOLVAPTAN?
Of the 560 reports, 63 (11.3%) resulted in death, 69 (12.3%) required hospitalization, and 2 (0.4%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOLVAPTAN. However, 560 reports have been filed with the FAERS database.
What Other Side Effects Does TOLVAPTAN Cause?
Death (800)
Thirst (624)
Renal impairment (534)
Underdose (448)
Product use in unapproved indication (446)
Wrong technique in product usage process (426)
Polyuria (390)
Product dose omission issue (379)
Inappropriate schedule of product administration (376)
Blood creatinine increased (337)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which TOLVAPTAN Alternatives Have Lower Off label use Risk?
TOLVAPTAN vs TOPAMAX
TOLVAPTAN vs TOPIRAMATE
TOLVAPTAN vs TOPOTECAN
TOLVAPTAN vs TOPOTECAN\TOPOTECAN
TOLVAPTAN vs TOPROL